NDC codes

FDA NDC Directory
Product NDC (as listed)82928-300Labeler and product segments. Claims need a package NDC.
Product NDC at billing width82928-0300Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
82928-300-04829280300044 BLISTER PACK in 1 CARTON (82928-300-04) / 1 TABLET in 1 BLISTER PACK (82928-300-01)Marketed from Jul 3, 2025
82928-300-05829280300052 BLISTER PACK in 1 CARTON (82928-300-05) / 2 TABLET in 1 BLISTER PACK (82928-300-02)Marketed from Jul 1, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Ekterly
Generic name (nonproprietary)
sebetralstat
Active ingredients
Sebetralstat — 300 mg/1
Dosage form
Tablet
Route
Oral
Labeler
KalVista Pharmaceuticals LtdNDC labeler code 82928
Product type
Prescription drug
Marketing category
NDA — New Drug ApplicationApplication NDA 219301
Marketing start
Listing expires
Other FDA classes
Kallikrein Inhibitors (Mechanism)
Identifiers
Product ID 82928-300_16d31d7e-dc21-4cdb-92b8-56919827a192SPL ID 16d31d7e-dc21-4cdb-92b8-56919827a192SPL set ID 1d145e2f-8e7e-2e90-e063-6294a90a4449RxCUI 2717949, 2717955UNII O5ZD2TU2B7UPC 0382928300012, 0382928300043, 0382928300029, 0382928300050
Pharmacologic class
Plasma Kallikrein Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N482928030004 followed by a unit qualifier and the quantity

Package 82928-0300-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

EKTERLY® is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older. EKTERLY ® is a plasma kallikrein inhibitor indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 82928-300

What is NDC 82928-300?
82928-300 is the product NDC for Ekterly (sebetralstat), Sebetralstat 300 mg/1 tablet, listed with the FDA by KalVista Pharmaceuticals Ltd. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Ekterly (Sebetralstat).
What is the active ingredient?
Sebetralstat.
Who is the labeler?
KalVista Pharmaceuticals Ltd, NDC labeler code 82928. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Ekterly?
None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in